Skip to main content

Sophia Cenac Weinmann

Assistant Professor of Medicine
Medicine, Rheumatology and Immunology

Selected Publications

Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors.

Journal Article Rheumatology (Oxford) · December 1, 2019 Immune checkpoint inhibitors are novel biologic agents to treat cancer by inhibiting the regulatory interactions that limit T cell cytotoxicity to tumours. Current agents target either CTLA-4 or the PD-1/PD-L1 axis. Because checkpoints may also regulate au ... Full text Open Access Link to item Cite